- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Kelly Rogers
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Melissa Call
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Shalin Naik
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Jim Whittle
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Nadia Kershaw
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Sarah Best
- Dr Saskia Freytag
- Dr Shabih Shakeel
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor Daniel Gray
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jeanne Tie
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marnie Blewitt
- Professor Matthew Ritchie
- Professor Melanie Bahlo
- Professor Melissa Davis
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Czabotar
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sandra Nicholson
- Professor Sant-Rayn Pasricha
- Professor Seth Masters
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A multi-pronged approach to targeting myeloproliferative neoplasms
- A new paradigm of machine learning-based structural variant detection
- A whole lot of junk or a treasure trove of discovery?
- Advanced imaging interrogation of pathogen induced NETosis
- Analysing the metabolic interactions in brain cancer
- Atopic dermatitis causes and treatments
- Boosting the efficacy of immunotherapy in lung cancer
- Building a cell history recorder using synthetic biology for longitudinal patient monitoring
- Characterisation of malaria parasite proteins exported into infected liver cells
- Deciphering the heterogeneity of the tissue microenvironment by multiplexed 3D imaging
- Defining the mechanisms of thymic involution and regeneration
- Delineating the molecular and cellular origins of liver cancer to identify therapeutic targets
- Developing computational methods for spatial transcriptomics data
- Developing drugs to block malaria transmission
- Developing models for prevention of hereditary ovarian cancer
- Developing statistical frameworks for analysing next generation sequencing data
- Development and mechanism of action of novel antimalarials
- Development of novel RNA sequencing protocols for gene expression analysis
- Discoveries in red blood cell production and function
- Discovering epigenetic silencing mechanisms in female stem cells
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Dissecting mechanisms of cytokine signalling
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- Epigenetic biomarkers of tuberculosis infection
- Epigenetics – genome wide multiplexed single-cell CUT&Tag assay development
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Exploiting the cell death pathway to fight Schistosomiasis
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- How do nutrition interventions and interruption of malaria infection influence development of immunity in sub-Saharan African children?
- Human lung protective immunity to tuberculosis
- Improving therapy in glioblastoma multiforme by activating complimentary programmed cell death pathways
- Innovating novel diagnostic tools for infectious disease control
- Integrative analysis of single cell RNAseq and ATAC-seq data
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigation of a novel cell death protein
- Malaria: going bananas for sex
- Mapping spatial variation in gene and transcript expression across tissues
- Mechanisms of Wnt secretion and transport
- Multi-modal computational investigation of single-cell communication in metastatic cancer
- Nanoparticle delivery of antibody mRNA into cells to treat liver diseases
- Naturally acquired immune response to malaria parasites
- Organoid-based discovery of new drug combinations for bowel cancer
- Organoid-based precision medicine approaches for oral cancer
- Removal of tissue contaminations from RNA-seq data
- Reversing antimalarial resistance in human malaria parasites
- Role of glycosylation in malaria parasite infection of liver cells, red blood cells and mosquitoes
- Screening for novel genetic causes of primary immunodeficiency
- Single-cell ATAC CRISPR screening – Illuminate chromatin accessibility changes in genome wide CRISPR screens
- Spatial single-cell CRISPR screening – All in one screen: Where? Who? What?
- Statistical analysis of single-cell multi-omics data
- Structural and functional analysis of epigenetic multi-protein complexes in genome regulation
- Structural basing for Wnt acylation
- Structure, dynamics and impact of extra-chromosomal DNA in cancer
- Targeted deletion of disease-causing T cells
- Targeting cell death pathways in tissue Tregs to treat inflammatory diseases
- The cellular and molecular calculation of life and death in lymphocyte regulation
- The role of hypoxia in cell death and inflammation
- The role of ribosylation in co-ordinating cell death and inflammation
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding cellular-cross talk within a tumour microenvironment
- Understanding the genetics of neutrophil maturation
- Understanding the roles of E3 ubiquitin ligases in health and disease
- Unveiling the heterogeneity of small cell lung cancer
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to understand malaria invasion and transmission
- Using structural biology to understand programmed cell death
- Validation and application of serological markers of previous exposure to malaria
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Ashley Weir
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jasmine Rou
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Krishneel Prasa
- Lilly Backshell
- Malvika Kharbanda
- Megan Kent
- Naomi Jones
- Pailene Lim
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Sophie Collard
- Wayne Cawthorne
- Wil Lehmann
- Yanxiang Meng
- Zhong Yan Gan
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A generous vision for impactful medical research
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Philanthropy through the power of sisterhood
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- Donors
- WEHI.TV
Sir Gustav Nossal

Director, 1965-1996
Sir Gustav Nossal is revered as an eminent immunologist and advocate for global health, and as an outstanding leader. In his 31 years as director, he increased the institute's scientific scope and size, nurturing new research programs and transforming the institute into the dynamic organisation it is today.
Nossal's outgoing personality and great gift for communication, coupled with a formidable scientific intellect, have made him one of Australia's foremost advocates for science. His influence and vision have created an enduring legacy. He continues to support the institute's research, staff and students in his role as patron.
- Read about Sir Gustav Nossal's discoveries and contributions on our Discovery Timeline
Contribution to immunology
As a young medical graduate, Sir Gustav Nossal came to the institute expecting to study virology. He arrived just at the time Sir Macfarlane Burnet had decided that the institute’s focus was to shift entirely to immunology research – and Sir Gustav Nossal became an immunologist.
His research greatly advanced understanding of how our immune system generates antibodies to protect us from infectious diseases. In addition, his ideas and experiments greatly clarified how the immune system learns to distinguish our own body from foreign invaders, how breakdown of this tolerance can lead to autoimmune diseases such as lupus and rheumatoid arthritis.
In 1965, Sir Gustav Nossal succeeded Sir Macfarlane Burnet as institute director.
Sir Macfarlane Burnet
As well as continuing to pursue his own successful research programs, as director Sir Gustav Nossal supported many globally significant research discoveries by institute researchers.
During this period the institute expanded its research scope to include haematology, parasitology, molecular biology and neural development. Immunology remained a central focus, and Nossal himself greatly advanced understanding of Burnet’s clonal selection theory and the immune system’s ‘tolerance to self’.
Funding priority
One of Sir Gustav Nossal’s first accomplishments as director was to put the institute on a firmer financial footing. He successfully persuaded the National Health and Medical Research Council to provide a triennial block grant, allowing our researchers to focus more on research than on securing research funding.
This policy was later extended to other major medical research institutes and was probably one of the most important factors contributing to the extraordinary success enjoyed today by Australian biomedical science.
Nurturing the best and brightest
Under Nossal’s leadership, many eminent scientists were drawn to the institute.
Professor Ian Mackay pioneered clinical research on autoimmunity and began treatment of autoimmunity with immunosuppressive drugs – still the gold standard today.
their research with Victorian Premier Sir Henry Bolte in 1966
Professor Don Metcalf discovered the colony stimulating factors (CSFs) that have now helped more than 20 million cancer patients worldwide to recover from chemotherapy, and which have revolutionised blood stem cell transplantation.
Immunology research continued to grow from its Burnet-era expansion. Professor Jacques Miller was recruited from London. Building on his seminal discovery of the function of the thymus, he discovered that T lymphocytes derived from the thymus helped B lymphocytes create antibodies. At the same time, Professor Ken Shortman began his groundbreaking analysis of T cell development, which expanded into studies of dendritic cells.
and Professor Ken Shortman in the 1970s
Professor Suzanne Cory and Professor Jerry Adams were recruited by Sir Gustav Nossal to introduce the nascent field of molecular biology to the institute. Their research first contributed to uncovering how the immune system generates diverse antibodies – by rearranging antibody genes within B cells. The research ventured into studies of gene rearrangements in leukaemia, and from there to understanding cell death, research which Professors Cory and Adams continue today.
Sir Gustav Nossal initiated a research program into globally significant parasitic diseases, including malaria, into the institute. The immunoparasitology research team, led by Dr Graham Mitchell, started in a small way but rapidly expanded. This was the foundation from which our Infection and Immunity researchers continue today.
New facilities
With the institute’s growth came a need for more space and state-of-the-art technology. Sir Gustav Nossal built up sophisticated scientific facilities such as proteomics and flow cytometry, and gained the funding required to build a new, purpose-built home for the institute.
The new building, the western wing of our present site behind The Royal Melbourne Hospital, was completed in 1985, and greatly enhanced our research capacity.
Warrior for global heath
Over several decades Sir Gustav has inspired and guided the national scientific agenda, and is known to be one of Australia’s foremost science advocates.
He has also been an energetic warrior for global health, most notably through his long-standing association with the World Health Organisation and more recently with the Bill and Melinda Gates Foundation. Sir Gustav also served as Deputy Chairman of the Council for Aboriginal Reconciliation from 1998 to 2000.
Awards and honours
Sir Gustav Nossal was knighted in 1977 for his pioneering research work in immunology, and was made a Companion of the Order of Australia in 1989. He was named Australian of the Year in 2000.
Internationally, Sir Gustav Nossal is a Fellow of the Royal Society of London, a Foreign Associate of the US National Academy of Sciences, and Member of the French Academie des Sciences.
In 2006 the Nossal Institute for Global Health was established and named in Sir Gustav Nossal’s honour, with a mission to improve the health of vulnerable communities.
Nossal interviews
In 2005 Sir Gustav was interviewed for the WEHI Revisited series (produced by Louise Darmody, Sound Memories), in which several institute luminaries spoke about what drove them to pursue a career in medical research, and shared memories of life at the institute.
- Gus Nossal’s childhood (7:50)
- Gus Nossal’s medical and scientific aspirations (7:23)
- Life at the Walter and Eliza Hall Institute (5:22)
- One cell, one antibody (4:41)
- Gus Nossal as director of the institute (10.25)
Diversity and Discovery
The remarkable advances in medical research between 1965 and 1996 coincided with the tenure of director Sir Gustav Nossal. As both a participant and keen observer, Nossal brings to life the exhilaration and the frustration of this revolutionary era.
Copies of this book can be ordered by phone +61 3 9345 2555. Cost $40 + P&H.